Immunotherapy with or without low-intensity chemotherapy versus conventional chemotherapy as first-line treatment for newly diagnosed B-ALL patients fit for intensive chemotherapy: a propensity score-matched study - Quiz - MDSpire

Immunotherapy with or without low-intensity chemotherapy versus conventional chemotherapy as first-line treatment for newly diagnosed B-ALL patients fit for intensive chemotherapy: a propensity score-matched study

  • By

  • Bingqian Huang

  • Yawen Wang

  • Yubin Li

  • Jiahui Mao

  • Ruixue Wang

  • Gaoyu Lv

  • Ming Hou

  • Yan Shi

  • June 18, 2026

  • 0 min

Share

Original Source(s)

Immunotherapy with or without low-intensity chemotherapy versus conventional chemotherapy as first-line treatment for newly diagnosed B-ALL patients fit for intensive chemotherapy: a propensity score-matched study

  • by Bingqian Huang, Yawen Wang, Yubin Li, Jiahui Mao, Ruixue Wang, Gaoyu Lv, Ming Hou, Yan Shi

  • June 18, 2026

Related Content

Hepatic metastasis of mucinous adenocarcinoma with neuroendocrine differentiation harboring a rare HER2 R678Q mutation: a case report and literature review

Distinct roles of nutritional and inflammatory signatures in predicting pathological response versus long-term survival in locally advanced gastric cancer treated with neoadjuvant immunotherapy

Endocrine therapy and thyroid function in early luminal breast cancer: a controlled longitudinal retrospective analysis